비디오 후두경 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트, 예측(2026-2034년)

Growth Factors of video laryngoscope Market

The global video laryngoscope market was valued at USD 581.11 million in 2025 and is projected to grow from USD 678.99 million in 2026 to USD 2,589.16 million by 2034, registering a strong CAGR of 18.21% during the forecast period (2026-2034).

North America dominated the market with a 47.03% share in 2025, supported by high adoption of advanced airway management devices, developed healthcare infrastructure, and strong presence of leading market players.

A video laryngoscope is a medical device that enables visualization of airway structures using a high-resolution video system. Unlike traditional direct laryngoscopes, which offer a limited view of the larynx, video laryngoscopes provide enhanced visualization, improving the success rate of endotracheal tube (ETT) placement, especially in difficult airway cases.

Market Trends

Technological Advancements and Disposable Device Adoption

One of the prominent trends in the market is the introduction of technologically advanced devices designed to improve safety and precision during intubation. Manufacturers are focusing on high-definition imaging, portable integrated display systems, and ergonomic designs to assist healthcare professionals during emergency airway procedures.

The increasing availability of fully disposable video laryngoscopes is another major trend. Disposable devices reduce cross-contamination risks and infection transmission, which became especially important after the COVID-19 pandemic. Companies such as Intersurgical Ltd. and other key players are expanding their portfolios with single-use options to meet infection control standards.

Inorganic growth strategies such as acquisitions and partnerships are also being adopted to strengthen global presence and product portfolios.

Market Driving Factors

Superiority Over Direct Laryngoscopy

The growing adoption of video laryngoscopes is largely driven by their clinical advantages over traditional direct laryngoscopy devices. Failed intubation attempts using direct laryngoscopes can lead to severe complications such as dental injury, laryngeal spasms, bronchospasm, cardiac arrest, and even fatalities.

Studies and clinical publications have demonstrated higher success rates and shorter intubation times with video laryngoscopes. According to surveys conducted by medical associations, difficult and failed intubation rates have declined significantly with the increasing use of video-based devices.

Additionally, the global rise in obesity prevalence and increasing emergency hospital admissions are contributing to the demand for advanced airway management tools. Difficult airway cases are more common among obese patients, further strengthening the need for visualization-based intubation devices.

Restraining Factors

High Cost and Limited Adoption in Emerging Markets

Despite strong growth potential, high device costs remain a key restraint. Reusable video laryngoscopes can cost between USD 1,000 and USD 8,000, significantly higher than traditional single-use laryngoscopes.

Emerging economies often face limited reimbursement coverage and budget constraints, restricting widespread adoption. Maintenance costs and availability of lower-cost alternatives also present challenges for market expansion.

Segmentation Analysis

By Product

The market is segmented into reusable and single-use video laryngoscopes.

The reusable segment dominated with an 88.48% share in 2026, owing to technical superiority, ease of operation during emergency procedures, and compatibility with disposable blades. However, the single-use segment is expected to grow at a significant rate due to increasing focus on infection control.

By Type

Based on type, the market is divided into cart-based models and integrated display models.

The cart-based segment held a dominant share of 63.07% in 2026, primarily due to strong product availability and higher pricing. However, integrated display models are projected to grow at a faster pace due to portability, compact design, and convenience in emergency and pre-hospital settings.

By End-Users

The market is categorized into hospitals, ENT clinics, and others (pre-hospital & EMS).

The hospitals segment held a dominant share of 89.83% in 2026, driven by a high number of surgeries requiring anesthesia and intubation. Increased surgical procedures and emergency admissions continue to support segment growth.

Regional Insights

North America

North America accounted for USD 273.27 million in 2025 and remained the largest regional market. The U.S. market is projected to reach USD 319.57 million in 2026, supported by advanced healthcare infrastructure and strong device adoption.

Europe

Europe is expected to witness significant CAGR growth due to increasing obesity rates and advanced healthcare systems.

• UK projected to reach USD 32.14 million by 2026
• Germany projected to reach USD 51.78 million by 2026

Asia Pacific

Asia Pacific is projected to grow rapidly due to expanding healthcare infrastructure and rising awareness of minimally invasive airway management.

• Japan projected to reach USD 53.34 million by 2026
• China projected to reach USD 45.72 million by 2026
• India projected to reach USD 15.59 million by 2026

Latin America and Middle East & Africa currently hold smaller shares due to limited awareness and affordability challenges.

Competitive Landscape

The market is consolidated, led by major players such as:

• Verathon Inc.
• Medtronic
• Ambu A/S
• KARL STORZ
• VYAIRE MEDICAL
• Intersurgical Ltd.

Strong product portfolios, global distribution networks, and innovation-driven strategies contribute to market leadership.

Conclusion

The global video laryngoscope market is set for robust expansion from USD 581.11 million in 2025 to USD 678.99 million in 2026, reaching USD 2,589.16 million by 2034, at a CAGR of 18.21%.

North America led the market in 2025 with a 47.03% share, driven by advanced healthcare systems and early technology adoption. Growth is primarily fueled by increasing difficult airway cases, rising obesity prevalence, technological advancements, and growing preference for minimally invasive intubation procedures.

Although high costs and limited reimbursement in emerging markets present challenges, continuous innovation, increasing surgical procedures, and expanding healthcare infrastructure worldwide are expected to sustain strong market growth through 2034.

Segmentation

By Product

• Reusable
• Single-use

By Type

• Integrated Display Models
• Cart-based Models

By End Users

• Hospitals
• ENT Clinics
• Others (Pre-hospital, EMS, etc.)

By Geography

• North America (the U.S. and Canada)
• Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and the Rest of Europe)
• Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and the Rest of Asia- Pacific)
• Latin America (Brazil, Mexico, and the Rest of Latin America)
• The Middle East & Africa (GCC, South Africa and the Rest of the Middle East & Africa)

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities

4. Key Insights

• 4.1. Pricing Analysis, by Key Players/ Brands, 2025
• 4.2. Technological Developments in Video Laryngoscopes
• 4.3. Impact of COVID-19 on Global Video Laryngoscope Market
• 4.4. Key Industry Developments - Mergers, Acquisition, Etc.

5. Global Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Key Findings / Summary
• 5.2. Market Analysis, Insights and Forecast - By Product
  • 5.2.1. Reusable
  • 5.2.2. Single-use
• 5.3. Market Analysis, Insights and Forecast - By Type
  • 5.3.1. Integrated Display Models
  • 5.3.2. Cart-based Models
• 5.4. Market Analysis, Insights and Forecast - By End User
  • 5.4.1. Hospitals
  • 5.4.2. ENT Clinics
  • 5.4.3. Others (Pre-hospital, EMS, etc.)
• 5.5. Market Analysis, Insights and Forecast - By Region
  • 5.5.1. North America
  • 5.5.2. Europe
  • 5.5.3. Asia Pacific
  • 5.5.4. Latin America
  • 5.5.5. Middle East & Africa

6. North America Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Key Findings / Summary
• 6.2. Market Analysis, Insights and Forecast - By Product
  • 6.2.1. Reusable
  • 6.2.2. Single-use
• 6.3. Market Analysis, Insights and Forecast - By Type
  • 6.3.1. Integrated Display Models
  • 6.3.2. Cart-based Models
• 6.4. Market Analysis, Insights and Forecast - By End User
  • 6.4.1. Hospitals
  • 6.4.2. ENT Clinics
  • 6.4.3. Others (Pre-hospital, EMS, etc.)
• 6.5. Market Analysis, Insights and Forecast - By Country
  • 6.5.1. U.S.
  • 6.5.2. Canada

7. Europe Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Key Findings / Summary
• 7.2. Market Analysis, Insights and Forecast - By Product
  • 7.2.1. Reusable
  • 7.2.2. Single-use
• 7.3. Market Analysis, Insights and Forecast - By Type
  • 7.3.1. Integrated Display Models
  • 7.3.2. Cart-based Models
• 7.4. Market Analysis, Insights and Forecast - By End User
  • 7.4.1. Hospitals
  • 7.4.2. ENT Clinics
  • 7.4.3. Others (Pre-hospital, EMS, etc.)
• 7.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.5.1. U.K.
  • 7.5.2. Germany
  • 7.5.3. France
  • 7.5.4. Spain
  • 7.5.5. Italy
  • 7.5.6. Scandinavia
  • 7.5.7. Rest of Europe

8. Asia pacific Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Key Findings / Summary
• 8.2. Market Analysis, Insights and Forecast - By Product
  • 8.2.1. Reusable
  • 8.2.2. Single-use
• 8.3. Market Analysis, Insights and Forecast - By Type
  • 8.3.1. Integrated Display Models
  • 8.3.2. Cart-based Models
• 8.4. Market Analysis, Insights and Forecast - By End User
  • 8.4.1. Hospitals
  • 8.4.2. ENT Clinics
  • 8.4.3. Others (Pre-hospital, EMS, etc.)
• 8.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.5.1. Japan
  • 8.5.2. China
  • 8.5.3. India
  • 8.5.4. Australia
  • 8.5.5. Southeast Asia
  • 8.5.6. Rest of Asia Pacific

9. Latin America Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Key Findings / Summary
• 9.2. Market Analysis, Insights and Forecast - By Product
  • 9.2.1. Reusable
  • 9.2.2. Single-use
• 9.3. Market Analysis, Insights and Forecast - By Type
  • 9.3.1. Integrated Display Models
  • 9.3.2. Cart-based Models
• 9.4. Market Analysis, Insights and Forecast - By End User
  • 9.4.1. Hospitals
  • 9.4.2. ENT Clinics
  • 9.4.3. Others (Pre-hospital, EMS, etc.)
• 9.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Rest of Latin America

10. Middle East & Africa Video Laryngoscope Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Key Findings / Summary
• 10.2. Market Analysis, Insights and Forecast - By Product
  • 10.2.1. Reusable
  • 10.2.2. Single-use
• 10.3. Market Analysis, Insights and Forecast - By Type
  • 10.3.1. Integrated Display Models
  • 10.3.2. Cart-based Models
• 10.4. Market Analysis, Insights and Forecast - By End User
  • 10.4.1. Hospitals
  • 10.4.2. ENT Clinics
  • 10.4.3. Others (Pre-hospital, EMS, etc.)
• 10.5. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.5.1. GCC Countries
  • 10.5.2. South Africa
  • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Key Industry Developments
• 11.2. Global Market Share Analysis (2021)
• 11.3. Competition Dashboard
• 11.4. Comparative Analysis - Major Players
• 11.5. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.5.1. Ambu A/S
    • 11.5.1.1. Overview,
    • 11.5.1.2. Products,
    • 11.5.1.3. SWOT Analysis,
    • 11.5.1.4. Recent Developments,
    • 11.5.1.5. Strategies,
    • 11.5.1.6. Financials (Based on Availability)
  • 11.5.2. KARL STORZ
    • 11.5.2.1. Overview,
    • 11.5.2.2. Products,
    • 11.5.2.3. SWOT Analysis,
    • 11.5.2.4. Recent Developments,
    • 11.5.2.5. Strategies,
    • 11.5.2.6. Financials (Based on Availability)
  • 11.5.3. Medtronic
    • 11.5.3.1. Overview,
    • 11.5.3.2. Products,
    • 11.5.3.3. SWOT Analysis,
    • 11.5.3.4. Recent Developments,
    • 11.5.3.5. Strategies,
    • 11.5.3.6. Financials (Based on Availability)
  • 11.5.4. Verathon, Inc.
    • 11.5.4.1. Overview,
    • 11.5.4.2. Products,
    • 11.5.4.3. SWOT Analysis,
    • 11.5.4.4. Recent Developments,
    • 11.5.4.5. Strategies,
    • 11.5.4.6. Financials (Based on Availability)
  • 11.5.5. VYAIRE
    • 11.5.5.1. Overview,
    • 11.5.5.2. Products,
    • 11.5.5.3. SWOT Analysis,
    • 11.5.5.4. Recent Developments,
    • 11.5.5.5. Strategies,
    • 11.5.5.6. Financials (Based on Availability)
  • 11.5.6. Marshall Products
    • 11.5.6.1. Overview,
    • 11.5.6.2. Products,
    • 11.5.6.3. SWOT Analysis,
    • 11.5.6.4. Recent Developments,
    • 11.5.6.5. Strategies,
    • 11.5.6.6. Financials (Based on Availability)
  • 11.5.7. Intersurgical Ltd
    • 11.5.7.1. Overview,
    • 11.5.7.2. Products,
    • 11.5.7.3. SWOT Analysis,
    • 11.5.7.4. Recent Developments,
    • 11.5.7.5. Strategies,
    • 11.5.7.6. Financials (Based on Availability)
  • 11.5.8. Vivid Medical, Inc.
    • 11.5.8.1. Overview,
    • 11.5.8.2. Products,
    • 11.5.8.3. SWOT Analysis,
    • 11.5.8.4. Recent Developments,
    • 11.5.8.5. Strategies,
    • 11.5.8.6. Financials (Based on Availability)
  • 11.5.9. Salter Labs
    • 11.5.9.1. Overview,
    • 11.5.9.2. Products,
    • 11.5.9.3. SWOT Analysis,
    • 11.5.9.4. Recent Developments,
    • 11.5.9.5. Strategies,
    • 11.5.9.6. Financials (Based on Availability)
  • 11.5.10. Prodol Meditec
    • 11.5.10.1. Overview,
    • 11.5.10.2. Products,
    • 11.5.10.3. SWOT Analysis,
    • 11.5.10.4. Recent Developments,
    • 11.5.10.5. Strategies,
    • 11.5.10.6. Financials (Based on Availability)

12. Strategic Recommendations